Yih‐Leong Chang - Concepedia

Author

Yih‐Leong Chang

National Taiwan University Hospital ORCID

Also Known As

A. I. Hatzitolios, Chang YL, Chang, Y., Christoph Holmer, S Sung, S. S. Peng, Y CHANG, Y Chang, Y L CHANG, Y L Chang

489

Publications

13.4K

Citations

H-Index

185

Concepts

All Affiliations

National Taiwan University Hospital National Taiwan University Institute of Biomedical Sciences, Academia Sinica National Cheng Kung University Far Eastern Memorial Hospital

About

Yih‐Leong Chang is an author at National Taiwan University Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	114	7.1K
2	Health Sciences	12	12	911
3	Natural Sciences	4	4	180
4	Engineering	2	2	34
5	Public Health	1	1	10

Yih‐Leong Chang

204

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug Shu Ping Wang, Wen-Lung Wang, Yih‐Leong Chang, Nature Cell Biology Mdm2-mediated DegradationMedicineCell DeathAnti-cancer AgentTumor Suppressor	2009	482
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling Wan-Jiun Chen, Chao‐Chi Ho, Yih‐Leong Chang, Nature Communications Lineage PlasticityParacrine SignallingMedicineCell PlasticityCancer-associated Fibroblasts	2014	438
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression Yi‐Ju Chen, Theodoros I. Roumeliotis, Ya-Hsuan Chang, Cell	2020	363
Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response Jenn‐Yu Wu, Shang‐Gin Wu, James Chih‐Hsin Yang, Clinical Cancer Research	2008	318
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes Ching‐Yao Yang, Mong‐Wei Lin, Yih‐Leong Chang, European Journal of Cancer Driver MutationsMedicinePathologyCell DeathProgrammed Cell	2014	287
MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 Ching Wen Lin, Yih‐Leong Chang, Yu-Chiuan Chang, Nature Communications Hippo PathwayMedicineMicrorna-135b PromotesCancer Cell BiologyCancer Genomics	2013	285
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai, Oncotarget	2016	234
Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma Yih‐Leong Chang, Yung-Chie Lee, Jin‐Yuan Shih, Lung Cancer Cell CarcinomaTumoral PathologyMedicineEar MoldingPathology	2001	221
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Chien‐Hung Gow, Yih‐Leong Chang, Yu‐Chia Hsu, Annals of Oncology Corresponding Metastatic TumorsMedicinePathologyBronchial NeoplasmCancer Biology	2008	212
Transcription Repressor<i>Slug</i>Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma Jin‐Yuan Shih, Meng-Feng Tsai, Tzu-Hua Chang, Clinical Cancer Research	2005	205

Page 1